New message from Marc LubowIt certainly appears that old Peternis being as obstinate as possible and reluctant to act in the best interests of shareholders and himself. Maybe he will grow a brain soon before we all suffer, nobody more than him.
Ladies & Gentlemen:
At the further request of Dr. Dallas Hack, Interim CEO/CFO and Director of CVR Medical, please find the following information.
Approximately 7 - 10 days ago, Company Counsel has sent the final version of the Definitive Agreement and License Agreement to the former CEO and the Board of Directors of CVR Global for review and execution. This would represent our 3rd iteration of this document, and in each prior instance, the former CEO has inserted language and terms counter to those contained in the mutually agreed upon Non-Binding Term Sheet. As of this writing, we have not received any further comments from CVR Global. We would encourage all shareholders to consider contacting the former CEO to inquire about the delays in completing this agreement, which surely would benefit both companies.
CVR Global holds the largest voting bloc (33M shares/26% of the vote) and is currently in conflict with CVR Medical whereas the two companies interests are not presently aligned and given that we are concerned that Global may not vote in the best interests of CVR Medical’s shareholders. As we have stated, the existing Officers and Directors (Dallas Hack, Paul Blunden), Board of Directors Nominee (Dr. Phillip Bendick), as well as the former Executive Officers and Directors who have been advising the Company, support the nominations and all initiatives contained in the circular (link below)
Circular (https://cvrmed.com/wp-cont